Skip to main content
Clinical Trials/NCT02891746
NCT02891746WithdrawnNot Applicable

The Neonatal Microbiome and Its Influence on the Post-partum Period

Hadassah Medical Organization2 sites in 1 countryStarted: September 7, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
2
Primary Endpoint
Definition the flora comprising the microbiome of premature and term babies

Study Overview

Brief Summary

The aim of the study is to characterize and monitor the microbiome of premature infants born in the investigators facility until discharge from the NICU. The investigators will also examine the relationship between mode of delivery and the microbiome of the infant, while exploring various possible factors that may affect it. In addition, the investigators will compare the microbiome of premature infants to the microbiome of term babies born at the same time in the same facility.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 50 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Premature infants ≤ 34 weeks of gestation admitted to the Neonatal Intensive Care Unit at Hadassah University Hospital, Mount Scopus and their mothers.
  • The control group:
  • Neonates ≥ 37 weeks gestation of which 50 were delivered vaginally and 50 by Caesarean section at Hadassah University Hospital, Mount Scopus and their mothers.

Exclusion Criteria

  • Neonates with congenital anomalies or metabolic conditions.

Outcomes

Primary Outcomes

Definition the flora comprising the microbiome of premature and term babies

Time Frame: birth

Secondary Outcomes

  • Difference in the microbiome of the infants born vaginally and via caesarian section(birth)
  • Change in the flora that constitutes the microbiome of premature babies(birth until adjusted age of 40 weeks gestation)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Maternal and Neonatal Microbiome | Clinical Trial